TransMedics to Host Investor & Analyst Day on December 10, 2024
TransMedics Group (Nasdaq: TMDX) has announced its upcoming Investor & Analyst Day scheduled for December 10, 2024, at 10:00 AM ET in New York City. The event will feature presentations from CEO Waleed Hassanein and the leadership team, focusing on the company's growth strategy, clinical pipeline, and operations.
The event will be accessible via live and archived webcast on the TransMedics website's Investors section. While questions during the Q&A session will be to the live audience, interested parties can register for in-person attendance by contacting Laine Morgan by December 4, 2024.
TransMedics Group (Nasdaq: TMDX) ha annunciato il suo prossimo Investor & Analyst Day in programma per il 10 dicembre 2024, alle 10:00 ET a New York City. L'evento presenterà interventi del CEO Waleed Hassanein e del team di direzione, focalizzandosi sulla strategia di crescita, il pipeline clinico e le operazioni.
L'evento sarà accessibile tramite webcast dal vivo e registrato nella sezione Investor del sito web di TransMedics. Durante la sessione di domande e risposte, le domande saranno rivolte al pubblico presente, ma le parti interessate possono registrarsi per partecipare di persona contattando Laine Morgan entro il 4 dicembre 2024.
TransMedics Group (Nasdaq: TMDX) ha anunciado su próximo Día de Inversores y Analistas programado para el 10 de diciembre de 2024, a las 10:00 AM ET en la ciudad de Nueva York. El evento contará con presentaciones del CEO Waleed Hassanein y del equipo de liderazgo, centrándose en la estrategia de crecimiento, el pipeline clínico y las operaciones.
El evento será accesible a través de un webcast en vivo y archivado en la sección de Inversores del sitio web de TransMedics. Mientras que las preguntas durante la sesión de preguntas y respuestas serán para el público en vivo, las partes interesadas pueden registrarse para asistir en persona contactando a Laine Morgan antes del 4 de diciembre de 2024.
TransMedics Group (Nasdaq: TMDX)는 2024년 12월 10일 오전 10시(ET) 뉴욕시에서 열릴 예정인 투자자 및 분석가의 날을 발표했습니다. 이 행사에서는 CEO Waleed Hassanein과 경영진이 참여하여 회사의 성장 전략, 임상 파이프라인 및 운영에 대해 발표할 예정입니다.
행사는 TransMedics 웹사이트의 투자자 섹션에서 실시간 및 아카이브 웹캐스트로 접근할 수 있습니다. Q&A 세션 중의 질문은 현장 청중을 위한 것이지만, 관련자는 2024년 12월 4일까지 Laine Morgan에게 연락하여 직접 참석 등록을 할 수 있습니다.
TransMedics Group (Nasdaq: TMDX) a annoncé son prochain Journée des Investisseurs et des Analystes prévue pour le 10 décembre 2024, à 10h00 ET à New York. L'événement comprendra des présentations du PDG Waleed Hassanein et de l'équipe dirigeante, axées sur la stratégie de croissance, le pipeline clinique et les opérations.
L'événement sera accessible par le biais d'un webinaire en direct et archivé dans la section Investisseurs du site Web de TransMedics. Bien que les questions durant la session de questions-réponses seront adressées au public présent, les parties intéressées peuvent s'inscrire pour une participation en personne en contactant Laine Morgan avant le 4 décembre 2024.
TransMedics Group (Nasdaq: TMDX) hat seinen bevorstehenden Investor & Analyst Day angekündigt, der am 10. Dezember 2024 um 10:00 Uhr ET in New York City stattfinden wird. Die Veranstaltung wird Präsentationen von CEO Waleed Hassanein und dem Führungsteam umfassen, die sich auf die Wachstumsstrategie, die klinische Pipeline und die Betriebsabläufe konzentrieren.
Die Veranstaltung wird über einen Live- und Archiv-Webcast im Investorenbereich der TransMedics-Website zugänglich sein. Während der Fragen und Antworten wird es Fragen aus dem Live-Publikum geben, interessierte Parteien können sich jedoch bis zum 4. Dezember 2024 bei Laine Morgan für eine persönliche Teilnahme anmelden.
- None.
- None.
Waleed Hassanein, MD., President and Chief Executive Officer, and members of the leadership team will present an overview of TransMedics' growth strategy, clinical pipeline, and operations.
A live and archived webcast of presentations and Q&A sessions will be available on the "Investors" section of the TransMedics website at https://investors.transmedics.com. Please note management will only take questions from the live audience during the question-and-answer session following the formal presentations.
In-person attendance at the event requires advanced registration. Please email Laine Morgan at laine@gilmartinir.com by December 4, 2024, for further information.
About TransMedics Group, Inc.
TransMedics is the world's leader in portable extracorporeal warm perfusion and assessment of donor organs for transplantation. Headquartered in
Investor Contact:
Brian Johnston
Laine Morgan
332-895-3222
Investors@transmedics.com
View original content to download multimedia:https://www.prnewswire.com/news-releases/transmedics-to-host-investor--analyst-day-on-december-10-2024-302316931.html
SOURCE TransMedics Group, Inc.
FAQ
When is TransMedics (TMDX) hosting its 2024 Investor & Analyst Day?
How can investors attend TransMedics (TMDX) Investor Day 2024?
What topics will be covered at TransMedics (TMDX) 2024 Investor Day?
What is the deadline to register for TransMedics (TMDX) 2024 Investor Day?
